Trial intelligence / Profile preview

Novel Exfoliative Serum with Chemical Peel for Photodamage

NCT05908825Completed

Sponsor
Austin Institute for Clinical Research
Start
Jun 2023
Primary completion
Nov 2023
Countries
1
01

Overview

Randomised, double-blind trial in photodamage, sponsored by Austin Institute for Clinical Research. Primary endpoints: Change in Product tolerability at Day 42 and Change in Product efficacy at Day 42. Started Jun 2023; status: completed.

02

Conditions

photodamage

Beyond the preview

Go deeper on NCT05908825.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05908825.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call